These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8788962)

  • 1. Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat.
    Monti JM; Monti D; Jantos H; Ponzoni A
    Neuropharmacology; 1995 Dec; 34(12):1647-51. PubMed ID: 8788962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness.
    Monti JM; Jantos H
    Neuropharmacology; 1994 May; 33(5):705-8. PubMed ID: 7936106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone.
    Monti JM; Jantos H; Silveira R; Reyes-Parada M; Scorza C
    Pharmacol Biochem Behav; 1995 Oct; 52(2):305-12. PubMed ID: 8577795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Schechter LE
    Behav Brain Res; 2013 Jul; 249():65-74. PubMed ID: 23624323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
    Monti JM; Jantos H
    Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
    Ponzoni A; Monti JM; Jantos H
    Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.
    Monti JM; Jantos H; Monti D; Alvariño F
    Sleep Res Online; 2000; 3(1):29-34. PubMed ID: 11382897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1-like receptor agonists enhance wakefulness.
    Dzoljic MR; Ukponmwan OE; Saxena PR
    Neuropharmacology; 1992 Jul; 31(7):623-33. PubMed ID: 1407402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin control of sleep-wake behavior.
    Monti JM
    Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions.
    Bjorvatn B; Ursin R
    Rev Neurosci; 1998; 9(4):265-73. PubMed ID: 9886141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
    Zgombick JM; Branchek TA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):503-8. PubMed ID: 9840417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual effect of 5-HT1B receptor stimulation on nociceptive dorsal horn neurones in rats.
    Gjerstad J; Tjølsen A; Hole K
    Eur J Pharmacol; 1997 Sep; 335(2-3):127-32. PubMed ID: 9369364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V; Ahlenius S
    Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.
    Ursin R; Bjorvatn B; Sommerfelt L; Underland G
    Behav Brain Res; 1989 Aug; 34(1-2):117-30. PubMed ID: 2527519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
    Monti JM; Jantos H; Lagos P
    Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain.
    Adell A; Celada P; Artigas F
    J Neurochem; 2001 Oct; 79(1):172-82. PubMed ID: 11595769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of accumbens m-chlorophenylbiguanide microinjections on sleep and waking in intact and 6-hydroxydopamine-treated rats.
    Monti JM; Ponzoni A; Jantos H; Lagos P; Silveira R; Banchero P
    Eur J Pharmacol; 1999 Jan; 364(2-3):89-98. PubMed ID: 9932710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration and local microinjection into the central nervous system of the 5-HT(7) receptor agonist LP-211 modify the sleep-wake cycle in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2014 Feb; 259():321-9. PubMed ID: 24286819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.